Verona Pharma (VRNA)
(Delayed Data from NSDQ)
$34.98 USD
+1.05 (3.09%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $34.97 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO11/4/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.88 |
Last EPS Surprise | -151.43% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.07 |
Next Year | -1.54 |
EPS (TTM) | -1.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.31M | 5.33M | 7.64M | 81.69M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 3.50M | 9.00M | 12.50M | 117.30M |
Low Estimate | 0.75M | 1.66M | 2.41M | 36.45M |
Year ago Sales | 0.00M | 0.00M | 0.46M | 7.64M |
Year over Year Growth Est. | NA | NA | 1,567.47% | 969.69% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.45 | -2.07 | -1.54 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | -1.20 |
High Estimate | -0.40 | -0.40 | -2.00 | -1.20 |
Low Estimate | -0.56 | -0.56 | -2.24 | -1.76 |
Year ago EPS | -0.18 | -0.16 | -0.72 | -2.07 |
Year over Year Growth Est. | -150.00% | -181.25% | -187.50% | 25.72% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.45 | -2.07 | -1.54 |
7 Days Ago | -0.45 | -0.45 | -2.07 | -1.54 |
30 Days Ago | -0.45 | -0.45 | -2.07 | -1.58 |
60 Days Ago | -0.45 | -0.45 | -2.07 | -1.60 |
90 Days Ago | -0.42 | -0.45 | -1.58 | -1.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.45 | -2.07 | -1.52 |
Zacks Consensus Estimate | -0.45 | -0.45 | -2.07 | -1.54 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 1.14% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.88 | -0.32 | -0.16 | -0.18 | NA |
Estimate | -0.35 | -0.24 | -0.23 | -0.27 | NA |
Difference | -0.53 | -0.08 | 0.07 | 0.09 | -0.11 |
Surprise | -151.43% | -33.33% | 30.43% | 33.33% | -30.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more